Ataxic Symptoms in Huntington's Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone

被引:14
|
作者
Egorova, Polina A. [1 ]
Gavrilova, Aleksandra V. [1 ]
Bezprozvanny, Ilya B. [1 ,2 ]
机构
[1] Peter Great St Petersburg Polytech Univ, Lab Mol Neurodegenerat, St Petersburg, Russia
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA
基金
俄罗斯科学基金会;
关键词
ataxia; cerebellum; Huntington's disease; transgenic mice; chlorzoxazone; BETA-III SPECTRIN; PURKINJE-CELLS; POTASSIUM CHANNELS; CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEAT; DOUBLE-BLIND; DYSFUNCTION; MOTOR; GENE; MODULATOR;
D O I
10.3389/fnins.2020.00279
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine expansion in the huntingtin protein, Striatum atrophy in HD leads to a progressive disturbance of psychiatric, motor, and cognitive function. Recent studies of HD patients revealed that the degeneration of cerebellum is also observed independently from the striatal atrophy during early HD stage and may contribute to the motor impairment and ataxia observed in HD. Cerebellar Purkinje cells (PCs) are responsible for the proper cerebellar pathways functioning and motor control. Recent studies on mouse models of HD have shown that the abnormality of the biochemical functions of PCs are observed in HD, suggesting the contribution of PC dysfunction and death to the impaired movement coordination observed in HD. To investigate ataxic symptoms in HD we performed a series of experiments with the yeast artificial chromosome transgenic mouse model of HD (YAC128). Using extracellular single-unit recording method we found that the portion of the cerebellar PCs with bursting and irregular patterns of spontaneous activity drastically rises in aged YAC128 HD mice when compared with wild type littermates. Previous studies demonstrated that SK channels are responsible for the cerebellar PC pacemaker activity and that positive modulation of SK channel activity exerted beneficial effects in different ataxic mouse models. Here we studied effects of the SK channels modulator chlorzoxazone (CHZ) on the motor behavior of YAC128 HD mice and also on the electrophysiological activity and neuroanatomy of the cerebellar PCs from these mice. We determined that the long-term intraperitoneal injections of CHZ alleviated the progressive impairment in the firing pattern of YAC128 PCs. We also demonstrated that treatment with CHZ rescued age-dependent motor incoordination and improved the cerebellar morphology in YAC128 mice. We propose that abnormal changes in the PC firing patterns might be a one of the possible causes of ataxic symptoms in HD and in other polyglutamine disorders and that the pharmacological activation of SK channels may serve as a potential way to improve the activity of cerebellar PCs and relieve the ataxic phenotype in HD patients.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease
    Andreassen, OA
    Dedeoglu, A
    Ferrante, RJ
    Jenkins, BG
    Ferrante, KL
    Thomas, M
    Friedlich, A
    Browne, SE
    Schilling, G
    Borchelt, DR
    Hersch, SM
    Ross, CA
    Beal, MF
    NEUROBIOLOGY OF DISEASE, 2001, 8 (03) : 479 - 491
  • [42] Behaviour changes in a transgenic model of Huntington's disease
    Klivenyi, P
    Bende, Z
    Hartai, Z
    Penke, Z
    Nemeth, H
    Toldi, J
    Vecsei, L
    BEHAVIOURAL BRAIN RESEARCH, 2006, 169 (01) : 137 - 141
  • [43] Genome-Wide Histone Acetylation Is Altered in a Transgenic Mouse Model of Huntington's Disease
    McFarland, Karen N.
    Das, Sudeshna
    Sun, Ting Ting
    Leyfer, Dmitri
    Xia, Eva
    Sangrey, Gavin R.
    Kuhn, Alexandre
    Luthi-Carter, Ruth
    Clark, Timothy W.
    Sadri-Vakili, Ghazaleh
    Cha, Jang-Ho J.
    PLOS ONE, 2012, 7 (07):
  • [44] "Brain training" improves cognitive performance and survival in a transgenic mouse model of Huntington's disease
    Wood, Nigel I.
    Glynn, Dervila
    Morton, A. Jennifer
    NEUROBIOLOGY OF DISEASE, 2011, 42 (03) : 427 - 437
  • [45] The methamphetamine-sensitive circadian oscillator is dysfunctional in a transgenic mouse model of Huntington's disease
    Cuesta, Marc
    Aungier, Juliet
    Morton, A. Jennifer
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 145 - 155
  • [46] From neuronal inclusions to neurodegeneration: neuropathological investigation of a transgenic mouse model of Huntington's disease
    Davies, SW
    Turmaine, M
    Cozens, BA
    Raza, AS
    Mahal, A
    Mangiarini, L
    Bates, GP
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 971 - 979
  • [47] Retinal Changes in the R6/1 Transgenic Mouse Model of Huntington's Disease
    Fletcher, E. L.
    Batcha, A. Hussain
    Greferath, U.
    Vessey, K. A.
    Nithianantharajah, J.
    Hannan, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [48] Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease
    Benn, C. L.
    Slow, E. J.
    Farrell, L. A.
    Graham, R.
    Deng, Y.
    Hayden, M. R.
    Cha, J.-H. J.
    NEUROSCIENCE, 2007, 147 (02) : 354 - 372
  • [49] Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington’s disease
    Dénes Zádori
    Gábor Nyiri
    András Szőnyi
    István Szatmári
    Ferenc Fülöp
    József Toldi
    Tamás F. Freund
    László Vécsei
    Péter Klivényi
    Journal of Neural Transmission, 2011, 118 : 865 - 875
  • [50] Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease
    Zadori, Denes
    Nyiri, Gabor
    Szonyi, Andras
    Szatmari, Istvan
    Fulop, Ferenc
    Toldi, Jozsef
    Freund, Tamas F.
    Vecsei, Laszlo
    Klivenyi, Peter
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (06) : 865 - 875